The webinar includes discussion of the latest European biotech patent case law developments including:

1. G 1/23: enablement requirement for products placed on the market forming part of the state of the art
2. Round up of recent decisions: subsequent data and second medical use claims:

• T 0709/23: post-published evidence undermining sufficiency
  
• T 0883/23: priority entitlement and the “same invention”
• T 0867/23: post-published evidence to support medical use claims

System requirements

To view our webinars we recommend the following internet browsers:

• Google Chrome (most recent 2 versions).
• Mozilla Firefox (most recent 2 versions).
• Apple Safari (most recent 2 versions).
• Microsoft Edge (most recent 2 versions).